Impact of prior use of antiplatelet agents and non-vitamin K antagonist oral anticoagulants on stroke outcomes among endovascular-treated patients with high pre-stroke CHA2DS2-VASc score.
Chulho KimJong-Hee SohnMinwoo LeeYerim KimHee Jung MoMi Sun OhKyung-Ho YuSang-Hwa LeePublished in: Journal of neurointerventional surgery (2023)
Prior use of NOAC is associated with improved outcomes in high-risk stroke patients (pre-stroke CHA2DS2-VASc score ≥2) undergoing EVT.